Zusammenfassung
Hintergrund
Die operative Therapie des Mammakarzinoms hat in den letzten Dekaden einen grundlegenden Wandel hin zu signifikant reduzierter Radikalität und Wahrung der onkologischen Sicherheit durchgemacht. In den letzten Jahren setzt sich dieser Trend weiter fort mit Änderungen im axillären Staging im Rahmen der Sentinel-Node-Biopsie (SNB) sowie reduzierter Radikalität im Sinne des Resektionsrandes. Gleichzeitig nehmen onkoplastische Operationsverfahren in Deutschland immer mehr zu, was belegt, dass es trotz reduzierter Radikalität weiterhin Indikationen zur Mastektomie gibt und geben wird. Dieser Trend reflektiert letztlich den vermehrten Wunsch nach ansprechenden kosmetischen Ergebnissen unter Wahrung der onkologischen Sicherheit.
Ziel der Arbeit
Die Arbeit versucht, einen Überblick über die aktuelle Literatur, Leitlinien und Empfehlungen zum Thema der lokoregionären Chirurgie insbesondere zum Thema Resektionsränder und Sentinel-Node-Biospsie zu geben. Des Weiteren sollen Indikationen, Zeitpunkt und operative Konzepte der rekonstruktiven Brustchirurgie beleuchtet werden.
Abstract
Background
In the last decades the operative treatment of breast cancer has undergone a fundamental change towards significantly reducing radicality and safeguarding oncological safety. This trend has continued in recent years with changes in axillary staging through sentinel lymph node biopsies (SNB) and reduced radicality with respect to the resection margins. Simultaneously, oncoplastic surgical procedures are steadily increasing in Germany, a trend which confirms that there are and always will be indications for mastectomy despite reduced radicality. This trend ultimately reflects the increased desire for aesthetically pleasing cosmetic results while safeguarding oncological safety.
Objectives
This article gives an overview of the current literature, guidelines and recommendations on the topic of locoregional surgery with particular emphasis on resection margins and sentinel lymph node biopsies. Furthermore, the indications, timing and operative concepts for reconstructive breast surgery are illustrated.
Literatur
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy. N Engl J Med 347:1233–1241
Veronesi U, Cascinelli N (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery. N Engl J Med 347:1227–1232
Wood C (2013) Close/positive margins after breast-conserving therapy: additional resection or no resection? Breast 22(Suppl 2):115–117
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
Wöckel A, Wolters R, Wiegel T et al (2014) The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. Ann Oncol 25(3):628–632
Luini A, Rsoschansky J, Gatti G et al (2009) The surgical margin status after breast conserving surgery: discussion of an open issue. Breast Cancer Res Treat 113(2):397–402
Houssami N, Macaskill P, Marinovich ML et al (2010) Meta-analysis of the impact of surgical margins on local recurrence in women with early stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 46(18):3219–3232
Morrow M (2008) Margins in breast-conserving therapy: have we lost sight of the big picture? Expert Rev Anticancer Ther 8(8):1193–1196
Morrow M (2009) Breast conservation and negative margins: how much is enough? Breast 18 (Suppl 3):S84-86
Fisher B, Anderson S, Redmonk CK et al (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333(22):1456–1461
S3 Leitlinie zur Diagnostik, Therapie und Nachsorge des Mammakarzinoms. 2012 http://www.awmf.org/uploads/tx_szleitlinien/032-045OL_l_S3__Brustkrebs_Mammakarzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf
Arbeitsgemeinschaft gynäkologische Onkologie (AGO) Empfehlungen 2014. http://www.ago-online.de/de/infothek-fuer-aerzte/leitlinienempfehlungen/mamma/
Dunne C, Burke JP, Morrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for Ductal carcinoma in situ. J Clin Oncol 27:1615–1620
Worni M, Greenup RA, Mackey AM, Akushevich I (2014) Trends in treatment patterns and outcomes for DCIS patients: a SEER population-based analysis. ASCO Annual Meeting 2014. J Clin Oncol 32:5s (suppl;abstr 1007)
Bergkvist L, Frisell J, Liljegren G et al (2001) Multicentre study of detection and falsenegative rates in sentinel node biopsy for breast cancer. Br J Surg 88(12):1644–1648
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma: a metaanalysis. Cancer 106(1):416
Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer a multicenter validation study. N Engl J Med 339(14):941–946
Tafra L, Lannin DR, Swanson MS et al (2001) Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233(1):51–59
Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Postoperative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279–293
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553
Giuliano AE, Haigh PI, Brennan MB et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18(13):2553–2559
Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426–432
DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500–515
Hennessy BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23(36):9304–9311
Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93(5):539–546
Palesty JA, Foster JM, Hurd TC et al (2006) Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 93(2):129–132
Smidt ML, Janssen CM, Kuster DM et al (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 12(1):29–33
Veronesi U, Orecchia R, Zurrida S et al (2005) Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 16(3):383–388
Zavagno G, Carcoforo P, Franchini Z et al (2005) Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 31(7):715–720
Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective multi-center cohort study. Lancet Oncol 14(7):609–618
Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455–1461
Lanitis S, Tekkis PP, Sgourakis G et al (2010) Comparison of skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg Oncol 251(4):632–639
Gerber B, Krause A, Dieterich M et al (2009) The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg 249(3):461–468
Sullivan SR, Fletcher DR, Isom CD, Isik FF (2008) True incidence of all complications following immediate and delayed breast reconstruction. Plas Reconstr Surg 122(1):19–28
Marques M, Browen SA, Oliveira I et al (2010) Marques 2010 Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases. Plas Reconstr Surg 126(3):769–778
Einhaltung ethischer Richtlinien
Interessenkonflikt. L. Schwentner, G. Müller-Bartusek, V. Fink und W. Janni geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwentner, L., Müller-Bartusek, G., Fink, V. et al. Innovationen in der operativen Therapie des Mammakarzinoms. Gynäkologe 47, 925–931 (2014). https://doi.org/10.1007/s00129-014-3370-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-014-3370-8